These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Author: Ferencz T, Skopál J, Csáki C, Laczkó M, Schuler D, Borsi J.
    Journal: Orv Hetil; 1993 Dec 26; 134(52):2873-5. PubMed ID: 8272354.
    Abstract:
    In approximately 10 to 15 percent of congenital hemophilia A patients circulating antibodies to factor VIII appear in the blood that poses a serious problem in their treatment. A number of methods and preparations are used in the clinical practice to overcome this problem. Authors report their favourable clinical experience with the administration of polyelectrolyte-fractionated porcine factor VIII. concentrate in a hemophiliac child for the first time in Hungary and a brief review of the clinical methods in use in the management of factor VIII. inhibitors.
    [Abstract] [Full Text] [Related] [New Search]